3CDE image
Deposition Date 2008-02-26
Release Date 2009-03-03
Last Version Date 2024-04-03
Entry Detail
PDB ID:
3CDE
Keywords:
Title:
Crystal structure of HCV NS5B polymerase with a novel Pyridazinone inhibitor
Biological Source:
Source Organism:
Hepatitis C virus (Taxon ID: )
Host Organism:
Method Details:
Experimental Method:
Resolution:
2.10 Å
R-Value Free:
0.22
R-Value Work:
0.19
R-Value Observed:
0.19
Space Group:
P 21 21 21
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:RNA-directed RNA polymerase
Mutations:R544Q
Chain IDs:A, B
Chain Length:578
Number of Molecules:2
Biological Source:Hepatitis C virus
Ligand Molecules
Primary Citation
Novel HCV NS5B polymerase inhibitors derived from 4-(1',1'-dioxo-1',4'-dihydro-1'lambda(6)-benzo[1',2',4']thiadiazin-3'-yl)-5-hydroxy-2H-pyridazin-3-ones. Part 3: Further optimization of the 2-, 6-, and 7'-substituents and initial pharmacokinetic assessments.
Bioorg.Med.Chem.Lett. 18 3446 3455 (2008)
PMID: 18457949 DOI: 10.1016/j.bmcl.2008.02.072

Abstact

5-Hydroxy-3(2H)-pyridazinone derivatives were investigated as inhibitors of genotype 1 HCV NS5B polymerase. Lead optimization led to the discovery of compound 3a, which displayed potent inhibitory activities in biochemical and replicon assays [IC(50) (1b)<10nM; IC(50) (1a)=22 nM; EC(50) (1b)=5nM], good stability toward human liver microsomes (HLM t(1/2)>60 min), and high ratios of liver to plasma concentrations 12h after a single oral administration to rats.

Legend

Protein

Chemical

Disease

Primary Citation of related structures